Abstract
Immune checkpoint inhibitors (ICIs) have emerged as a powerful and efficacious therapeutic approach for many cancer patients. Sintilimab is a fully hu......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
